Celomide 5mg Capsule Abu Dhabi | Top Pharma Exporter from India

Celomide 5mg Capsule: Leading Immunomodulatory Therapy for Oncology Care

Are you searching for a reliable Celomide 5mg Capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced oncology medications. We cater to high-demand international markets, including the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, providing high-quality pharmaceutical solutions with professional B2B support.

Product Overview: What is Celomide 5mg?

Celomide 5 mg is an oral medication containing Lenalidomide. It belongs to a sophisticated class of drugs known as Immunomodulatory Agents (IMiDs). Celomide is a cornerstone in the treatment of various hematological malignancies, offering a targeted approach to managing complex blood and bone marrow cancers.

Primary Therapeutic Indications: 

Celomide 5mg is clinically indicated for the management of:

• Multiple Myeloma (MM): Used in combination with dexamethasone for patients who have received at least one prior therapy or for newly diagnosed patients.

• Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

• Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after prior therapies.

• Follicular Lymphoma (FL): In combination with rituximab for previously treated patients.

Mechanism of Action: How Celomide Works:

Celomide operates through a multifaceted mechanism to combat malignant cells and support the patient's immune response:

1. Direct Tumor Inhibition: It induces cell cycle arrest and apoptosis (programmed cell death) in hematopoietic tumor cells.

2. Immune System Modulation: It enhances T cell and Natural Killer (NK) cell-mediated immunity, significantly boosting the body's natural ability to destroy cancer cells.

3. Anti-Angiogenesis: It inhibits the growth of new blood vessels (angiogenesis) that tumors need to grow and spread.

4. Cytokine Regulation: It reduces the production of pro-inflammatory cytokines like TNF-α, creating an unfavorable environment for tumor survival.

Dosage and Administration Guidelines: 

• Cycle-Based Therapy: Often prescribed in 28-day cycles (e.g., daily for 21 days followed by a 7-day rest period).

• Administration: Capsules must be swallowed whole with water, at approximately the same time each day. Do not break, chew, or open the capsules.

• Special Precautions: Due to its structural relationship to thalidomide, Celomide is subject to strict pregnancy prevention programs (REMS) globally.

• Monitoring: Regular blood counts (CBC) are essential to monitor for bone marrow suppression (neutropenia and thrombocytopenia).

Common Side Effects: 

Healthcare providers should monitor patients for:

• Fatigue, diarrhea, and nausea.

• Increased risk of Venous Thromboembolism (blood clots).

• Skin rashes or itching.

• Low white blood cell or platelet counts.

Why Source Celomide 5 mg from Ernest Oncology?

• Global Logistics Mastery: Direct shipping and rapid delivery to the USA, UK, UAE, Australia, and South Africa.

• Quality Assurance: Authentic medications sourced from GMP-compliant manufacturers in India.

• Bulk Supply Availability: Constant inventory of 5 mg, 10 mg, 15 mg, and 25 mg strengths for hospital and clinical supply.

• B2B Competitive Pricing: Optimized rates for international pharmaceutical distributors and oncology centers.